help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2007-2780
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Freda, P. U.
Right arrow Articles by Gallagher, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Freda, P. U.
Right arrow Articles by Gallagher, D.
Related Collections
Right arrow Neuroendocrinology and Pituitary
Right arrow Endocrine Oncology
Right arrow Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 93, No. 6 2334-2343
Copyright © 2008 by The Endocrine Society

Lower Visceral and Subcutaneous but Higher Intermuscular Adipose Tissue Depots in Patients with Growth Hormone and Insulin-Like Growth Factor I Excess Due to Acromegaly

Pamela U. Freda, Wei Shen, Steven B. Heymsfield, Carlos M. Reyes-Vidal, Eliza B. Geer, Jeffrey N. Bruce and Dympna Gallagher

Departments of Medicine (P.U.F., C.M.R.-V.) and Neurosurgery (J.N.B.), Columbia University College of Physicians and Surgeons, New York, New York 10032; Obesity Research Center St. Luke’s-Roosevelt Hospital (W.S., S.B.H., D.G.), Columbia University, New York, New York 10025; Department of Medicine (E.B.G.), Mt. Sinai Medical Center, New York, New York 10029; and Merck Research Laboratories (S.B.H.), Rahway, New Jersey 07065

Address all correspondence and requests for reprints to: Pamela U. Freda M.D., Department of Medicine, Columbia University, College of Physicians and Surgeons, 650 West 168th Street, 9-905, New York, New York 10032. E-mail: puf1{at}columbia.edu.

Context: GH and IGF-I are important regulators of metabolism and body composition. In acromegaly, a state of GH and IGF-I excess, the lipolytic and insulin antagonistic effects of GH may alter adipose tissue (AT) distribution.

Objectives: Our objective was to test the hypothesis that in acromegaly whole-body AT mass is less and to examine for the first time the relationship between GH/IGF-I excess and intermuscular AT (IMAT), an AT depot associated with insulin resistance in other populations.

Design, Setting, and Patients: We conducted a cross-sectional study in 24 adults with active acromegaly compared with predicted models developed in 315 healthy non-acromegaly subjects.

Outcome Measures: Mass of AT in the visceral AT (VAT), sc AT (SAT), and IMAT compartments from whole-body magnetic resonance imaging and serum levels of GH, IGF-I, insulin, and glucose were measured.

Results: VAT and SAT were less in active acromegaly (P < 0.0001); these were 68.2 ± 27% and 79.5 ± 15% of predicted values, respectively. By contrast, IMAT was greater (P = 0.0052) by 185.6 ± 84% of predicted. VAT/trunk AT ratios were inversely related to IGF-I levels (r = 0.544; P = 0.0054). Acromegaly subjects were insulin resistant.

Conclusions: VAT and SAT, most markedly VAT, are less in acromegaly. The proportion of trunk AT that is VAT is less with greater disease activity. IMAT is greater in acromegaly, a novel finding, which suggests that increased AT in muscle could be associated with GH-induced insulin resistance. These findings have implications for understanding the role of GH in body composition and metabolic risk in acromegaly and other clinical settings of GH use.




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. Vettor, G. Milan, C. Franzin, M. Sanna, P. De Coppi, R. Rizzuto, and G. Federspil
The origin of intermuscular adipose tissue and its pathophysiological implications
Am J Physiol Endocrinol Metab, November 1, 2009; 297(5): E987 - E998.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
P. Kamenicky, C. Dos Santos, C. Espinosa, S. Salenave, F. Galland, Y. Le Bouc, P. Maison, P. Bougneres, and P. Chanson
D3 GH receptor polymorphism is not associated with IGF1 levels in untreated acromegaly
Eur. J. Endocrinol., August 1, 2009; 161(2): 231 - 235.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. U. Freda, W. Shen, C. M. Reyes-Vidal, E. B. Geer, F. Arias-Mendoza, D. Gallagher, and S. B. Heymsfield
Skeletal Muscle Mass in Acromegaly Assessed by Magnetic Resonance Imaging and Dual-Photon X-Ray Absorptiometry
J. Clin. Endocrinol. Metab., August 1, 2009; 94(8): 2880 - 2886.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
N. Moller and J. O. L. Jorgensen
Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects
Endocr. Rev., April 1, 2009; 30(2): 152 - 177.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. B. Heymsfield, T. Chirachariyavej, I. J. Rhyu, C. Roongpisuthipong, M. Heo, and A. Pietrobelli
Differences between brain mass and body weight scaling to height: potential mechanism of reduced mass-specific resting energy expenditure of taller adults
J Appl Physiol, January 1, 2009; 106(1): 40 - 48.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society